2020
DOI: 10.1186/s13000-020-01039-2
|View full text |Cite
|
Sign up to set email alerts
|

Hepatic epithelioid hemangioendothelioma: case series of a rare vascular tumor mimicking metastases

Abstract: Background Hepatic epithelioid hemangioendothelioma is an extremely rare malignant vascular tumor which is often multifocal and, in many cases, discovered incidentally. Here, we describe the clinicopathological features of hepatic epithelioid hemangioendothelioma cases seen in our practice and present a detailed review of the published literature. Methods All cases of hepatic epithelioid hemangioendothelioma diagnosed in Department o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(13 citation statements)
references
References 25 publications
0
12
0
1
Order By: Relevance
“…Histologically, HEHE manifests as nests and cords of spindle to epithelioid cells with mild to moderate atypia, abundant pale to eosinophilic cytoplasm, indistinct cell boundaries, and intracytoplasmic vacuolations in a fibromyxoid stroma. 4 Older lesions appear sclerotic, calcified, or necrosed. 2 …”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Histologically, HEHE manifests as nests and cords of spindle to epithelioid cells with mild to moderate atypia, abundant pale to eosinophilic cytoplasm, indistinct cell boundaries, and intracytoplasmic vacuolations in a fibromyxoid stroma. 4 Older lesions appear sclerotic, calcified, or necrosed. 2 …”
Section: Discussionmentioning
confidence: 99%
“…There is no consensus for a gold standard of treatment, however, there is agreement that treatment should consider the involvement of both liver lobes, lesion size/number, and disease progression. 4 Treatment includes radiation, chemotherapy, liver resection, and liver transplant. While agents targeting anti-angiogenesis have had the most success in clinical trials, common chemotherapeutics include doxorubicin, vincristine, interferon-alpha, 5-fluorouracil, thalidomide, and monoclonal antibodies against vascular endothelial growth factor.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations